New cancer drugs 2023

Comment

Author: Admin | 2025-04-28

Text on survivorship"Surveillance has become more important than ever for those with testicular cancer. Since the last testicular cancer guideline was released, the model for management has substantially changed, making an amendment like this critical to effectively treat and manage testicular cancer,” said Andrew Stephenson, MD, in a news release on the updates.2 Stephenson is the director of urologic oncology at Rush University Medical Center in Chicago, Illinois and a member of the 2023 amendment panel for testicular cancer.Both the LUTS/BPH and testicular cancer guidelines were updated based on the availability of new literature, as identified through an AUA Update Literature Review process.References1. AUA releases amendment to the management of lower urinary tract symptoms attributed to benign prostatic hyperplasia guideline. News release. American Urological Association. September 14, 2023. Accessed September 18, 2023. https://www.prnewswire.com/news-releases/aua-releases-amendment-to-the-management-of-lower-urinary-tract-symptoms-attributed-to-benign-prostatic-hyperplasia-guideline-301928085.html2. AUA releases amendment to the diagnosis and treatment of early-stage testicular cancer guideline. News release. American Urological Association. September 14, 2023. Accessed September 18, 2023. https://www.prnewswire.com/news-releases/aua-releases-amendment-to-the-diagnosis-and-treatment-of-early-stage-testicular-cancer-guideline-301928122.html3. Sandhu JS, Bixler BR, Dahm P, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA Guideline amendment 2023. J Urol. 2023;10.1097/JU.0000000000003698. https://doi.org/10.1097/JU.00000000000036984. Stephenson A, Bass EB, Bixler BR, et al. Diagnosis and treatment of early-stage testicular cancer: AUA Guideline amendment 2023. J Urol. 2023;10.1097/JU.0000000000003694. https://doi.org/10.1097/JU.0000000000003694

Add Comment